LARP1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.852800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.803400E-01
Normal-vs-Stage2
2.703800E-01
Normal-vs-Stage3
8.640400E-01
Normal-vs-Stage4
1.157790E-01
Stage1-vs-Stage2
9.786600E-01
Stage1-vs-Stage3
2.129400E-01
Stage1-vs-Stage4
1.881000E-01
Stage2-vs-Stage3
1.480440E-01
Stage2-vs-Stage4
4.456500E-02
Stage3-vs-Stage4
4.301900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.672000E-01
Normal-vs-AfricanAmerican
2.642000E-01
Normal-vs-Asian
8.966800E-01
Caucasian-vs-AfricanAmerican
5.059000E-01
Caucasian-vs-Asian
6.788300E-02
AfricanAmerican-vs-Asian
1.173650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.005200E-01
Normal-vs-Female
2.798000E-01
Male-vs-Female
8.889400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.951200E-01
Normal-vs-Age(41-60Yrs)
1.984210E-01
Normal-vs-Age(61-80Yrs)
3.262400E-01
Normal-vs-Age(81-100Yrs)
5.073200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.696000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.579200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.368200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.034000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.217200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.849800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.949200E-01
Normal-vs-Daily Drinker
5.114000E-01
Normal-vs-Weekly Drinker
6.371400E-01
Normal-vs-Occasional Drinker
1.772610E-01
Normal-vs-Social Drinker
3.341000E-01
Non Drinker-vs-Daily Drinker
2.901000E-01
Non Drinker-vs-Weekly Drinker
3.797200E-01
Non Drinker-vs-Occasional Drinker
6.830800E-01
Non Drinker-vs-Social Drinker
7.906800E-01
Daily Drinker-vs-Weekly Drinker
9.608800E-01
Daily Drinker-vs-Occasional Drinker
1.523810E-01
Daily Drinker-vs-Social Drinker
2.744400E-01
Weekly Drinker-vs-Occasional Drinker
2.463200E-01
Weekly Drinker-vs-Social Drinker
3.742000E-01
Occasional Drinker-vs-Social Drinker
9.417600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.134640E-01
Normal-vs-Grade 2
1.963870E-02
Normal-vs-Grade 3
2.438400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.939000E-01
Grade 1-vs-Grade 3
9.135400E-01
Grade 1-vs-Grade 4
1.134640E-01
Grade 2-vs-Grade 3
3.382600E-01
Grade 2-vs-Grade 4
1.963870E-02
Grade 3-vs-Grade 4
2.438400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.594800E-01
Normal-vs-NonDiabetic
3.106400E-01
Diabetic-vs-NonDiabetic
3.672200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.696800E-01
Normal-vs-NoPancreatitis
3.383600E-01
Pancreatitis-vs-NoPancreatitis
8.821200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.109000E-01
Normal-vs-N1
2.559000E-01
N0-vs-N1
5.402800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.752100E-02
Normal-vs-TP53-NonMutant
1.875420E-01
TP53-Mutant-vs-TP53-NonMutant
9.822400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
